1 Of the 145,410 patients treated with GLP1 and 291,667 treated with dipeptidyl peptidase 4 (DPP4) inhibitor treatment, 76 and 184, respectively, developed thyroid cancer
However, hair loss during GLP-1 therapy is multifactorial, and a supplement alone may not fully resolve it
Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase
Studies on L-carnitine appear to be all over the board, but it is clear that it will only be beneficial in weight loss when calorie consumption is also reduced to facilitate the burning of fat
Documentation of pre-existing diarrhea, abdominal pain, or fat intolerance is critical for informed risk-benefit discussion